tradingkey.logo
tradingkey.logo
Search

Xtant Medical Holdings Inc

XTNT
Add to Watchlist
0.320USD
-0.007-2.14%
Close 09-18 16:00ET
45.59MMarket Cap
24.70P/E TTM
After-hours 16:10 (ET)0.320USD-0.005-1.54%

More Details of Xtant Medical Holdings Inc Company

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.

Xtant Medical Holdings Inc Profile

Ticker SymbolXTNT
Company nameXtant Medical Holdings Inc
IPO dateJun 30, 2010
CEOBrowne (Sean E)
Number of employees217
Security typeOrdinary Share
Fiscal year-endJun 30
Address664 Cruiser Lane
CityBELGRADE
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code59714
Phone14063880480
Websitehttps://xtantmedical.com/
Ticker SymbolXTNT
IPO dateJun 30, 2010
CEOBrowne (Sean E)

Company Executives of Xtant Medical Holdings Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.29M
+4.44%
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.29M
+4.44%
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.29M
+4.44%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
971.40K
+22.19%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
971.40K
+22.19%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
971.40K
+22.19%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer, Assistant Secretary
Chief Financial Officer, Assistant Secretary
742.11K
+50.11%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer, Assistant Secretary
Chief Financial Officer, Assistant Secretary
742.11K
+50.11%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer, Assistant Secretary
Chief Financial Officer, Assistant Secretary
742.11K
+50.11%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
373.75K
+57.66%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.29M
+4.44%
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.29M
+4.44%
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.29M
+4.44%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
971.40K
+22.19%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
971.40K
+22.19%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
971.40K
+22.19%

FAQs

Who are the top five shareholders of Xtant Medical Holdings Inc?

The top five shareholders of Xtant Medical Holdings Inc are: Mr. Stavros G. Vizirgianakis

What is the biggest source of revenue for Xtant Medical Holdings Inc?

In 2026Q4, the Orthobiologics business generated the highest revenue for Xtant Medical Holdings Inc, amounting to 17.36M and accounting for 75.38% of total revenue.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.